Literature DB >> 11290786

Increased transcription levels induce higher mutation rates in a hypermutating cell line.

J Bachl1, C Carlson, V Gray-Schopfer, M Dessing, C Olsson.   

Abstract

Somatic hypermutation, in addition to V(D)J recombination, is the other major mechanism that generates the vast diversity of the Ab repertoire. Point mutations are introduced in the variable region of the Ig genes at a million-fold higher rate than in the rest of the genome. We have used a green fluorescent protein (GFP)-based reversion assay to determine the role of transcription in the mutation mechanism of the hypermutating cell line 18-81. A GFP transgene containing a premature stop codon is transcribed from the inducible tet-on operon. Using the inducible promoter enables us to study the mutability of the GFP transgene at different transcription levels. By analyzing stable transfectants of a hypermutating cell line with flow cytometry, the mutation rate at the premature stop codon can be measured by the appearance of GFP-positive revertant cells. Here we show that the mutation rate of the GFP transgene correlates with its transcription level. Increased transcription levels of the GFP transgene caused an increased point mutation rate at the premature stop codon. Treating a hypermutating transfection clone with trichostatin A, a specific inhibitor of histone deacetylase, caused an additional 2-fold increase in the mutation rate. Finally, using Northern blot analysis we show that the activation-induced cytidine deaminase, an essential trans-factor for the in vivo hypermutation mechanism, is transcribed in the hypermutating cell line 18-81.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290786     DOI: 10.4049/jimmunol.166.8.5051

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Variable deletion and duplication at recombination junction ends: implication for staggered double-strand cleavage in class-switch recombination.

Authors:  X Chen; K Kinoshita; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Directed evolution of mammalian anti-apoptosis proteins by somatic hypermutation.

Authors:  Brian S Majors; Gisela G Chiang; Nels E Pederson; Michael J Betenbaugh
Journal:  Protein Eng Des Sel       Date:  2011-12-09       Impact factor: 1.650

3.  Somatic hypermutation of the AID transgene in B and non-B cells.

Authors:  Alberto Martin; Matthew D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-29       Impact factor: 11.205

4.  Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation.

Authors:  Maki Kobayashi; Zahra Sabouri; Somayeh Sabouri; Yoko Kitawaki; Yves Pommier; Takaya Abe; Hiroshi Kiyonari; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-11       Impact factor: 11.205

Review 5.  Technologies of directed protein evolution in vivo.

Authors:  Artem Blagodatski; Vladimir L Katanaev
Journal:  Cell Mol Life Sci       Date:  2010-12-29       Impact factor: 9.261

Review 6.  Does DNA repair occur during somatic hypermutation?

Authors:  Huseyin Saribasak; Patricia J Gearhart
Journal:  Semin Immunol       Date:  2012-06-22       Impact factor: 11.130

7.  Evolution of new nonantibody proteins via iterative somatic hypermutation.

Authors:  Lei Wang; W Coyt Jackson; Paul A Steinbach; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

8.  Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias.

Authors:  Zheng Xiao; Madhumita Ray; Chuancang Jiang; Alan B Clark; Igor B Rogozin; Marilyn Diaz
Journal:  Mol Immunol       Date:  2007-01-22       Impact factor: 4.407

Review 9.  Evaluation of molecular models for the affinity maturation of antibodies: roles of cytosine deamination by AID and DNA repair.

Authors:  Mala Samaranayake; Janusz M Bujnicki; Michael Carpenter; Ashok S Bhagwat
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

10.  RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.

Authors:  Tomonori Eto; Kazuo Kinoshita; Kiyotsugu Yoshikawa; Masamichi Muramatsu; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.